DJ AstraZeneca PLC ADR Falls Monday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
The AstraZeneca PLC ADR $(AZN)$ slipped 1.27% to $69.86 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.20% to 19,391.96 and Dow Jones Industrial Average falling 0.28% to 44,421.91.
This was the ADR's second consecutive day of losses.
AstraZeneca PLC ADR closed 20.32% below its 52-week high of $87.68, which the company reached on August 30th.
The ADR underperformed when compared to some of its competitors Monday, as Eli Lilly & Co. $(LLY)$ fell 0.08% to $810.43, Biogen Inc. $(BIIB)$ fell 1.10% to $142.34, and Johnson & Johnson $(JNJ)$ fell 0.18% to $151.87.
Trading volume (5.0 M) remained 281,902 below its 50-day average volume of 5.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 3, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 03, 2025 17:23 ET (22:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.